Project description
Biocompatible 4D materials for bone regeneration in MRONJ patients
Biocompatible 4D materials for bone regeneration in MRONJ patients Medication-related osteonecrosis of the jaw (MRONJ) is a rare but severe side effect of bone-targeting agents (BTAs) such as bisphosphonates, prescribed to breast cancer survivors to lower the risk of secondary bone cancer. MRONJ can cause progressive jawbone destruction, leading to infections, difficulty eating, and malnutrition. The EU-funded GreenNanoBone project will develop sustainable, biocompatible, and antimicrobial 4D materials that promote bone and tissue regeneration for the prevention and treatment of MRONJ. This injectable or printable material will be designed for non-invasive surgical use, with AI to optimise plant-derived substances and ensure compliance with medical standards. The project will uncover the mechanisms behind MRONJ, improve the quality of life, and offer new treatment options for complex fractures.
Objective
PROBLEM: Medical-related-osteonecrosis of jaw (MRONJ) is a rare, but severe side effect of bone-targeting agents (BTAs), such as bisphosphonates. These agents are prescribed to survivors of breast cancer where they reduce the risk of secondary bone cancer. Unfortunately some people develop MRONJ, where progressive destruction of the jawbone leads to frequent infections, inability to eat and risk of malnutrition. MRONJ treatment focuses on controlling infection, pain and bone death through long courses of antimicrobial agents, contributing to development of antimicrobial resistance. Currently, ~12,000 people across Europe and the UK suffer from MRONJ. As people survive cancer longer, the number of cases is increasing. We urgently need a new prevention and treatment strategy for MRONJ.
INNOVATION: GreenNanoBone will develop and validate sustainable, biocompatible, bioactive and antimicrobial 4D material to promote bone and tissue regeneration in a new strategy to prevent and treat MRONJ. The material will be injectable or printable as a scaffold for use in non-invasive surgical procedures. We will use AI to refine the properties of our plant-derived materials, test them using pre-clinical models, and ensure that they can be manufactured to medical standards.
IMPACT: We address a clinical need and will reveal the pathophysiological mechanism of MRONJ in readiness for Phase I clinical trials (TLR-6) by the end of the project. In the longer term GreenNanoBone will dramatically increase quality of life for MRONJ patients and open up exciting possibilities for treating complex fractures and other skeletal conditions. We will develop a sustainable manufacturing process using recycling and clean raw material from a food (potato) waste side stream. The technology will enable production scale-up using climate-neutral methods. Our work will support European industries to undergo a Green Transformation and develop new markets, products, and services, boosting competitiveness.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine oncology
- engineering and technology nanotechnology nano-materials
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.2.4 - Digital, Industry and Space
MAIN PROGRAMME
See all projects funded under this programme -
HORIZON.2.4.4 - Advanced Materials
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-IA - HORIZON Innovation Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-CL4-2024-RESILIENCE-01-TWO-STAGE
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
L69 7ZX LIVERPOOL
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.